Literature DB >> 20970818

PAR-4 and hTERT expression are negatively correlated after RNA interference targeting hTERT in laryngocarcinoma cells.

Jian-Fei Sheng1, Wei Chen, Yan Yu, Jun Liu, Ze-Zhang Tao.   

Abstract

We investigated the relationship between telomerase activity and the expression of human telomerase reverse transcriptase (hTERT) and prostate apoptosis response 4 (Par-4) proteins in laryngocarcinoma cells. Following treatment with short hairpin RNA (shRNA) against hTERT, hTERT protein expression was inhibited, while Par-4 expression was increased. These changes were statistically significant (p<0.05), with Par-4 and hTERT expression being negatively correlated (p<0.05, r=-0.908). However, we found no correlation between telomerase activity and hTERT expression. Our findings suggest that hTERT exerts its anti-apoptotic effects through a telomerase-independent pathway, which is likely to intersect with the Par-4 apoptosis pathway.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20970818     DOI: 10.1016/j.tice.2010.08.002

Source DB:  PubMed          Journal:  Tissue Cell        ISSN: 0040-8166            Impact factor:   2.466


  3 in total

Review 1.  A journey beyond apoptosis: new enigma of controlling metastasis by pro-apoptotic Par-4.

Authors:  Reyaz Ur Rasool; Debasis Nayak; Souneek Chakraborty; Archana Katoch; Mir Mohd Faheem; Hina Amin; Anindya Goswami
Journal:  Clin Exp Metastasis       Date:  2016-08-27       Impact factor: 5.150

2.  hTERT gene knockdown enhances response to radio- and chemotherapy in head and neck cancer cell lines through a DNA damage pathway modification.

Authors:  Wojciech Barczak; Agnieszka Sobecka; Pawel Golusinski; Michal M Masternak; Blazej Rubis; Wiktoria M Suchorska; Wojciech Golusinski
Journal:  Sci Rep       Date:  2018-04-13       Impact factor: 4.379

3.  TERT and Akt Are Involved in the Par-4-Dependent Apoptosis of Islet β Cells in Type 2 Diabetes.

Authors:  Chen Liu; Wu QiNan; Lei XiaoTian; Yang MengLiu; Gan XiaGuang; Leng WeiLing; Liang ZiWen; Zhang Ling; Yang GangYi; Chen Bing
Journal:  J Diabetes Res       Date:  2018-08-14       Impact factor: 4.011

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.